StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
564
This month
2
This year
232
Publishing Date
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 19
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
5
2023 - 04 - 12
3
2023 - 03 - 28
4
2023 - 03 - 10
4
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 08
3
2023 - 01 - 11
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 29
3
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
3
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 11 - 25
2
2021 - 11 - 12
2
2021 - 11 - 04
2
2021 - 10 - 27
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 14
2
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Sector
Communications
4
Consumer durables
1
Consumer non-durables
14
Electronic technology
1
Energy minerals
3
Finance
58
Finance and insurance
1
Health services
1
Health technology
564
Manufacturing
53
Mining, quarrying, and oil and gas extraction
1
N/a
107
Process industries
14
Producer manufacturing
8
Professional, scientific, and technical services
2
Retail trade
1
Tags
Acne
6
Active
8
Agreement
6
Ajovy
6
Alzheimer's
8
America
31
Application
11
Approval
10
Asia
12
Austedo
8
Avt02
10
Avt04
9
Biosimilar
31
Business
11
Cancer
18
Children
18
Collaboration
9
Conference
18
Dermatitis
7
Disease
33
Drug
39
Dupixent
34
Earnings
12
Europe
15
Events
9
Expected
10
Fda
21
Financial
17
Global
95
Growing
16
Growth
119
Health
10
Libtayo
8
License
10
Liver
8
Market
272
Migraine
7
N/a
457
Pharm-country
18
Pharma
11
Pharmaceuticals
8
Phase 1
7
Phase 3
15
Positive
13
Reach
11
Report
81
Research
52
Respiratory
9
Results
40
Review
7
Set
7
Stelara
9
Study
17
System
10
Teva
43
Therapeutics
57
Therapy
12
Treatment
72
Trial
11
Update
18
Entities
3m company
868
Abb ltd
1301
Abbott laboratories
1543
Abbvie inc.
908
Accenture plc
540
Alphabet inc.
1101
Amgen inc.
694
Apple inc.
1091
Arcelormittal
500
Arrival
3798
Astrazeneca plc
587
Athena consumer acquisition corp.
523
Becton, dickinson and company
722
Bnp paribas
1628
Boston scientific corporation
524
Bristol-myers squibb company
596
Broadcom inc.
521
Cisco systems, inc.
808
Danaher corporation
724
Dell technologies inc.
516
Dow inc.
521
Eli lilly and company
1546
Ericsson
1459
Extreme networks, inc.
581
First bank
557
Ford motor company
564
Gartner, inc.
523
General electric company
851
Glaxosmithkline plc
825
Honeywell international inc.
1612
Hubspot, inc.
1290
Intel corporation
874
International business machines corporation
604
Johnson & johnson
3972
Kering
1005
Koninklijke philips n.v.
884
Lithium corp
869
Live nation entertainment, inc.
717
Lockheed martin corporation
519
Medtronic plc
1192
Microsoft corporation
1126
Morgan stanley
3637
Nokia corp
884
Nokia corporation
824
Northrop grumman corporation
532
Novartis ag
1108
Novo nordisk a/s
566
Oracle corporation
1080
Orange
6070
Panasonic corp
590
Pfizer, inc.
642
Sanofi
3985
Sap se
1377
Snowflake inc.
705
Teva pharmaceutical industries ltd
564
Thermo fisher scientific inc
1427
Total se
1577
Verizon communications inc.
1056
Vision sensing acquisition corp.
498
X financial
562
Symbols
ABBV
108
ABT
35
AKRX
4
ALB
8
ALC
4
ALKS
5
ALNY
4
ALPMF
20
ALPMY
20
ALVO
69
AMGN
67
ATR
5
AZN
70
AZNCF
70
BAX
22
BHC
30
BIIB
22
BMY
28
CMXHF
6
CNY
5
CSLLY
6
ENDP
25
ENDPQ
16
GILD
8
GLAXF
132
GSK
132
INR
5
JAZZ
6
JNJ
68
KMDA
71
LLY
48
MDT
9
MLPY
5
MMM
8
MNK
13
MNKKQ
11
MNKPF
8
MS
5
MYL
34
NTLA
6
NVO
14
NVS
182
NVSEF
182
OAC
53
PFE
28
PHG
10
PRGO
5
RBGLY
11
RBGPF
11
REGN
72
SNY
198
SNYNF
198
TAK
15
TEVA
57
TEVJF
564
TMO
5
UCBJF
5
UCBJY
5
URR
5
VTRS
90
Exchanges
Nasdaq
564
Nyse
425
Crawled Date
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
6
2023 - 03 - 28
4
2023 - 03 - 10
3
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
4
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 31
2
2022 - 01 - 21
2
2022 - 01 - 19
3
2022 - 01 - 18
2
2022 - 01 - 11
2
2021 - 12 - 08
3
2021 - 12 - 01
2
2021 - 11 - 25
2
2021 - 11 - 12
2
2021 - 11 - 04
2
2021 - 10 - 27
3
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 14
2
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Crawled Time
00:00
24
00:20
6
01:00
16
02:00
11
03:00
13
04:00
9
04:20
4
05:00
8
06:00
16
07:00
15
08:00
24
08:20
1
09:00
36
10:00
20
11:00
21
12:00
42
12:15
1
12:20
9
12:30
3
13:00
34
13:20
8
13:30
6
14:00
18
14:20
2
14:30
5
15:00
18
15:20
1
15:30
6
16:00
25
16:20
4
17:00
20
18:00
18
19:00
23
20:00
16
20:20
4
21:00
21
22:00
28
23:00
28
Source
ir.biolinerx.com
1
ir.vtvtherapeutics.com
1
www.biospace.com
107
www.globenewswire.com
80
www.prnewswire.com
375
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Teva pharmaceutical industries ltd
save search
Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37% of market growth - Technavio
Published:
2023-12-01
(Crawled : 00:20)
- prnewswire.com
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
RMD
|
$159.64
1.21%
0.0%
700K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$8.5
5.21%
100
|
Health Technology
|
Email alert
Add to watchlist
IFNNF
|
$38.3
-3.99%
-13.37%
11K
|
Electronic Technology
|
Email alert
Add to watchlist
RSMDF
S
|
$
0%
|
Health Technology
|
Email alert
Add to watchlist
IFNNY
|
$39.38
1.76%
0.0%
110K
|
Manufacturing
|
Email alert
Add to watchlist
america
smart
technology
growth
market
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 23:00)
- prnewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$8.5
5.21%
100
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
G
|
$272.45
1.04%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
companies
astrazeneca
cancer
therapeutics
market
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-0.35%
|
O:
-0.35%
H:
0.0%
C:
0.0%
TEVA
|
$9.71
-1.12%
0.0%
6.6M
|
Health Technology
|
1.34%
|
O:
-0.52%
H:
3.73%
C:
1.87%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
-0.17%
|
O:
-1.09%
H:
0.0%
C:
0.0%
disease
treatment
collaboration
teva
deal
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published:
2023-11-29
(Crawled : 15:30)
- prnewswire.com
VTRS
|
$9.37
2.07%
0.0%
7.4M
|
Health Technology
|
0.0%
|
O:
0.11%
H:
0.44%
C:
-0.22%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
UTHR
|
$240.73
0.3%
0.0%
310K
|
Health Technology
|
4.17%
|
O:
0.27%
H:
0.0%
C:
0.0%
GILD
|
$77.65
1.37%
-0.05%
5.4M
|
Health Technology
|
2.8%
|
O:
0.46%
H:
0.8%
C:
0.51%
research
hypertension
market
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published:
2023-11-29
(Crawled : 09:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
avt05
simponi
biosimilar
positive
results
study
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Open-Angle Glaucoma Therapeutics Market size to grow by USD 2.36 billion from 2022 to 2027, North America to account for 51% of market growth - Technavio
Published:
2023-11-28
(Crawled : 06:00)
- prnewswire.com
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
-0.23%
|
O:
-0.74%
H:
0.08%
C:
-0.22%
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
5.86%
|
O:
1.48%
H:
1.17%
C:
0.29%
ALC
|
$75.85
0.29%
0.0%
970K
|
Health Technology
|
2.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.62%
|
O:
0.19%
H:
0.0%
C:
0.0%
america
glaucoma
therapeutics
growth
market
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published:
2023-11-27
(Crawled : 23:00)
- prnewswire.com
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
0.62%
|
O:
-0.5%
H:
0.0%
C:
0.0%
KPTI
|
$0.7908
2.7%
-0.1%
1.8M
|
Health Technology
|
8.03%
|
O:
4.0%
H:
1.93%
C:
-7.72%
AMGN
G
|
$272.45
1.04%
0.0%
2.3M
|
Health Technology
|
1.97%
|
O:
0.03%
H:
0.85%
C:
0.44%
report
hope
treatment
research
global
virus
therapy
market
Gonorrhea Therapeutics Market to grow by USD 506.68 million from 2022 to 2027; North America accounts for 39% of market growth - Technavio
Published:
2023-11-21
(Crawled : 20:00)
- prnewswire.com
GLAXF
|
$18.25
5.74%
-0.49%
3.8K
|
Health Technology
|
-3.9%
|
O:
-3.23%
H:
0.0%
C:
-0.35%
GSK
|
$36.57
1.61%
-0.06%
2.5M
|
Health Technology
|
1.72%
|
O:
-0.23%
H:
0.2%
C:
-0.28%
america
therapeutics
growth
market
Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET
Published:
2023-11-21
(Crawled : 13:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
5.56%
|
O:
-0.56%
H:
1.94%
C:
0.67%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
0.21%
|
O:
-0.21%
H:
1.06%
C:
0.85%
conference
report
business
update
financial
results
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
4.67%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
P
|
$50.1
1.46%
0.08%
13M
|
Health Technology
|
-2.87%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.97%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
$77.65
1.37%
-0.05%
5.4M
|
Health Technology
|
2.08%
|
O:
-0.13%
H:
0.0%
C:
0.0%
reach
research
hiv
market
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Published:
2023-11-17
(Crawled : 16:00)
- biospace.com/
TEVA
|
$9.71
-1.12%
0.0%
6.6M
|
Health Technology
|
12.1%
|
O:
1.26%
H:
0.0%
C:
0.0%
HALO
|
$39.69
2.8%
2.22%
1M
|
Health Technology
|
-1.25%
|
O:
1.65%
H:
0.0%
C:
0.0%
forteo
approval
teva
Digital Dose Inhaler Market Set for Remarkable Growth, Estimated at $104.3 Billion by 2033
Published:
2023-11-16
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$18.25
5.74%
-0.49%
3.8K
|
Health Technology
|
1.23%
|
O:
0.59%
H:
0.0%
C:
0.0%
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
2.67%
|
O:
-2.16%
H:
4.44%
C:
2.2%
GSK
|
$36.57
1.61%
-0.06%
2.5M
|
Health Technology
|
4.41%
|
O:
-0.41%
H:
0.0%
C:
0.0%
MMM
|
$99.85
0.79%
0.04%
2.8M
|
Producer Manufacturing
|
2.96%
|
O:
0.25%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
1.69%
|
O:
-0.22%
H:
0.71%
C:
0.6%
set
market
Global Epinephrine Markets, 2017-2022, 2022-2027F, 2032F: Product Innovation Drives Growth, Rising Prevalence of Chronic Respiratory Diseases Driving Demand
Published:
2023-11-14
(Crawled : 15:30)
- prnewswire.com
VTRS
|
$9.37
2.07%
0.0%
7.4M
|
Health Technology
|
0.11%
|
O:
-0.44%
H:
0.0%
C:
0.0%
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
9.26%
|
O:
4.13%
H:
0.0%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
9.12%
|
O:
0.94%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
2.51%
|
O:
0.68%
H:
0.0%
C:
0.0%
respiratory
innovation
global
epinephrine
Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara® (ustekinumab)
Published:
2023-11-14
(Crawled : 12:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
5.32%
|
O:
-0.22%
H:
0.0%
C:
0.0%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
6.15%
|
O:
0.17%
H:
0.0%
C:
0.0%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.25%
|
O:
0.21%
H:
0.0%
C:
0.0%
avt04
stelara
pharma
biosimilar
authorization
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
Published:
2023-11-13
(Crawled : 13:30)
- biospace.com/
TEVA
|
$9.71
-1.12%
0.0%
6.6M
|
Health Technology
|
11.46%
|
O:
-2.38%
H:
4.53%
C:
2.56%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
5.62%
|
O:
-0.5%
H:
0.0%
C:
0.0%
RPRX
|
$27.35
1.03%
0.59%
4.5M
|
Health Technology
|
-1.6%
|
O:
-1.49%
H:
0.59%
C:
0.04%
pharma
royalty
teva
program
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
Published:
2023-11-13
(Crawled : 13:00)
- globenewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
5.62%
|
O:
-0.5%
H:
0.0%
C:
0.0%
RPRX
|
$27.35
1.03%
0.59%
4.5M
|
Health Technology
|
-1.6%
|
O:
-1.49%
H:
0.59%
C:
0.04%
pharma
royalty
teva
program
Challenges in Transparency and Control Hamper Merchant API Market Growth Despite Pharmaceutical Industry Expansion
Published:
2023-11-10
(Crawled : 00:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
LZAGY
|
$38.46
-0.41%
0.0%
110K
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$8.5
5.21%
100
|
Health Technology
|
Email alert
Add to watchlist
LZAGF
|
$384.0
-1.03%
-7.81%
960
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
control
expansion
growth
market
STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
Published:
2023-11-10
(Crawled : 14:30)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
9.32%
|
O:
3.57%
H:
0.0%
C:
0.0%
biosimilar
chmp
positive
stelara
← Previous
1
2
3
4
5
6
7
8
9
…
28
29
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
BKKT
4
|
$1.88
25.33%
14.89%
4.8M
|
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
CCJ
|
$45.4
-1.13%
4.6%
3.9M
|
Non-Energy Minerals
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
SAIC
4
|
$119.92
2.14%
4.24%
460K
|
Technology Services
CULP
4
|
$5.06
-0.59%
3.95%
29K
|
Process Industries
LGL
4
|
$4.94
1.23%
3.04%
15K
|
Electronic Technology
MPLN
|
$1.33
2.31%
3.01%
1.1M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.